Human epidermal growth factor receptor 2 (HER2) known as an oncogene, confers a more aggressive tumor and is associated with an increased rate of recurrence, mortality, and metastatic disease despite the remarkable progress in treatment [14-15]. The gene discussed is ERBB2; the disease is metastatic neoplasm.